Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 22, Number 5—May 2016
CME ACTIVITY - Research

Spectrum of Viral Pathogens in Blood of Malaria-Free Ill Travelers Returning to Canada

Ruwandi Kariyawasam, Rachel Lau, Alireza Eshaghi, Samir N. Patel, Doug Sider, Jonathan B. Gubbay, and Andrea K. BoggildComments to Author 
Author affiliations: Public Health Ontario Laboratories, Toronto, Ontario, Canada (R. Kariyawasam, R. Lau, A. Eshaghi, S.N. Patel, J.B. Gubbay, A.K. Boggild); University of Toronto, Toronto (S.N. Patel, J.B. Gubbay, A.K. Boggild); Public Health Ontario, Toronto (D. Sider); McMaster University, Hamilton, Ontario, Canada (D. Sider); Toronto General Hospital, Toronto (A.K. Boggild)

Main Article

Table 3

Region of travel for patients from Canada who had viral pathogen–positive specimens after returning ill from travel, May 2006–April 2007 and February 2013–March 2014*

Viral pathogen Total no. pathogens detected No. (%) specimens with patient travel history noted Region of travel, no. patients
HSV
HSV-1 7 4 (57.1) Afghanistan, 1; Caribbean, 1; Haiti, 1; Hawaii, 1
HSV-2
14
6 (42.9)
Dominican Republic, 3; India, 1; Sri Lanka, 1; Venezuela, 1
EBV
194
96 (47.7)
Indian subcontinent, 34; Caribbean, 21; Africa, 17; South America, 7; Central America, 5; Southeast Asia, 5; North America, 4; Middle East, 3
CMV
4
2 (50.0)
Pakistan, 1; South America, 1
Chikungunya virus
5
3 (60.0)
Barbados, 1; Philippines, 1; South Africa, 1
Dengue virus, serotype 33 20 (60.6)
DENV-1 12 10 (83.3) Barbados, 4; Cambodia, 1; Caribbean, 1; Dominican Republic, 1; India, 1; Sri Lanka, 1; Trinidad, 1
DENV-2 3 3 (100) Bangladesh, 1; Cuba, 1; Tanzania, 1
DENV-3 9 2 (22.2) Indonesia, 1; Philippines/Vietnam, 1
DENV-4 3 2 (66.7) Vietnam, 2
Untypeable dengue
6
3 (50.0)
Guyana, 1; Malaysia, 1; Yemen, 1
Untypeable flavivirus
2
1 (50.0)
Barbados, 1
HAV 12 4 (33.3) Pakistan, 3; Bangladesh, 1

*Data are for 129 (49.2%) of 262 EDTA-containing specimens. CMV, cytomegalovirus; DENV-1–4, dengue virus type 1–4; EBV, Epstein-Barr virus; HAV, hepatitis A virus; HSV-1 and 2, herpes simplex 1 and 2 virus.

Main Article

Page created: April 02, 2018
Page updated: April 02, 2018
Page reviewed: April 02, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external